By capping Medicare out-of-pocket expenses at $2000 a year, the Inflation Reduction Act will allow more patients with heart failure to access lifesaving treatments, cardiologists say.
Advances in maternal and child health, prevention of post-stroke disability and finding new uses for old medicines are among the top developments in 2022, according to the AHA s annual list.
Patients with both diabetes and heart failure who were treated with sotagliflozin, a novel investigational drug for diabetes, for a median of nine to 16 months experienced reductions of 22% to 43% in the risk of death or worsening heart failure compared with similar patients who were treated with a placebo, according to research presented at the American College of Cardiology s 70th Annual Scientific Session.